Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Genesis (New York, N.Y. : 2000)|October 7, 2014
Generation of a Tlx1(CreER-Venus) knock-in mouse strain for the study of spleen developmentRyo Nakahara, Yasuhiro Kawai, Akihisa Oda, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|April 3, 2007
Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous propertiesYuko Sugihara-Mizuno, Makoto Adachi, Yuka Kobayashi, et al.
Molecular Immunology|October 31, 2015
High affinity IgM(+) memory B cells are generated through a germinal center-dependent pathwayYasushi Hara, Yasuyuki Tashiro, Akikazu Murakami, et al.
Archives of Biochemistry and Biophysics|December 1, 2009
Evaluation of the conformational equilibrium of reduced hen egg lysozyme by antibodies to the native formMasayuki Oda, Aki Kitai, Akikazu Murakami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expressionMiyuki Nishimura, Hisanori Umehara, Takashi Nakayama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors alpha and betaHiroyoshi Ishizaki, Atsushi Togawa, Miki Tanaka-Okamoto, et al.
Surgery|April 23, 2013
Inhibition of CCL20 increases mortality in models of mouse sepsis with intestinal apoptosisYoshihiro Kitagawa, Shojiro Kikuchi, Yoshihisa Arita, et al.
International Immunology|November 29, 2013
Low-affinity IgM antibodies lacking somatic hypermutations are produced in the secondary response of C57BL/6 mice to (4-hydroxy-3-nitrophenyl)acetyl haptenAkikazu Murakami, Hayato Moriyama, Mina Osako-Kabasawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[A case of advanced gastric cancer acquired long-term response two years or more by treatment with oral anticancer drug TS-1]Jun Itakura, Namiki Izumi, Kazunari Inoue, et al.
Pageof 3